tiprankstipranks
NKGen Biotech (NKGN)
NASDAQ:NKGN
US Market
Holding NKGN?
Track your performance easily

NKGen Biotech (NKGN) Financial Statements

78 Followers

NKGen Biotech Financial Overview

NKGen Biotech's market cap is currently ―. The company's EPS TTM is $-4.922; its P/E ratio is -0.07; NKGen Biotech is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -16.09M$ -7.64M$ -45.40M$ -32.97M$ -3.04M
EBITDA$ -15.76M$ -7.31M$ -45.01M$ -32.97M$ -3.04M
Net Income Common Stockholders$ -16.09M$ -5.38M$ -33.61M$ -33.18M$ 8.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 79.00K$ 34.00K$ 26.00K$ 8.80M$ 635.15K
Total Assets$ 15.65M$ 16.32M$ 16.48M$ 25.20M$ 174.37M
Total Debt$ 20.83M$ 20.86M$ 19.92M$ 20.04M$ 0.00
Net Debt$ 20.75M$ 20.82M$ 19.89M$ 11.24M$ -635.15K
Total Liabilities$ 85.36M$ 71.37M$ 75.17M$ 65.84M$ 5.37M
Stockholders Equity$ -69.72M$ -55.05M$ -58.69M$ -40.64M$ -4.17M
Cash Flow-
Free Cash Flow$ -6.00M$ -4.00M$ -6.94M$ -13.95M$ -576.50K
Operating Cash Flow$ -6.00M$ -4.03M$ -6.94M$ -13.95M$ -576.50K
Investing Cash Flow$ -15.00K$ 35.00K$ -18.00K$ -113.38M$ 568.64K
Financing Cash Flow$ 6.06M$ 4.01M$ -1.80M$ 136.84M$ -85.00K
Currency in USD

NKGen Biotech Earnings and Revenue History

NKGen Biotech Debt to Assets

NKGen Biotech Cash Flow

NKGen Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis